Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 3 March 2027
- Last conf. stmt
- 17 February 2026
Cambridge Molecular Diagnostics Ltd
- Incorporated
- 20 May 2015 (11 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Reencara Limited
- Owned by
- Cotterford Company Limited
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- 25 Science ParkBio-Innovation CentreMilton RoadCambridgeCB4 0FW
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Reencara Limited
Corporate Director · Appointed 4 June 2024
Director · Appointed 20 June 2022
Also at Express Test Investments Ltd · more companies
British
Born January 1957 (69)
Officer history (7 former)
11 December 2025
Resigned Cerda Moya, Gustavo Andrés, Dr as Director
1 November 2025
Resigned Shaw, Benjamin Fraser Adam as Director
4 June 2024
Resigned Isosceles Finance Ltd as Corporate Director
4 June 2024
Appointed Reencara Limited as Corporate Director
6 February 2023
6 February 2023
Resigned Hussain, Sam as Director
20 June 2022
14 September 2018
14 September 2018
Appointed Hussain, Sam as Director
14 September 2018
Appointed Isosceles Finance Ltd as Corporate Director
10 March 2016
Appointed Shaw, Benjamin Fraser Adam as Director
27 November 2015
27 November 2015
4 June 2015
4 June 2015
20 May 2015
Appointed Cerda Moya, Gustavo Andrés, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Cotterford Company Limited
Corporate entity · Notified 1 May 2026
Owns 50–75% of shares
Holds 50–75% of voting rights
Limited Company
Reg. no. 001906v
Former controllers (1)
11 December 2025
Ceased Gustavo Cerda Moya — Owns 25–50% of shares
Financials
Balance sheet as at 31 December 2025 · total exemption full accounts
- Net Assets
- £2,494,684
- Cash
- £9,822
- Profit
- (£171,709)
- Employees
- 6
- Debt Ratio
- 18%
- Current Ratio
- 0.3x
- Return on Equity
- -7%
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £2,854,824 | £2,399,611 | £1,751,058 | £1,282,413 | £935,830 | £712,481 | £368,759 |
| Current Assets | £177,168 | £252,773 | £596,605 | £358,952 | £295,586 | £560,250 | £217,373 |
| Cash | £9,822 | £39,977 | £418,851 | £176,595 | £172,566 | £451,304 | £110,858 |
| Creditors (< 1 year) | £537,308 | £357,620 | £43,968 | £785,727 | £53,951 | £16,256 | £6,872 |
| Creditors (> 1 year) | £0 | £680,000 | £640,000 | ||||
| Net Current Assets | (£360,140) | (£104,847) | £552,637 | (£426,775) | £241,635 | £543,994 | £210,501 |
| Net Assets | £2,494,684 | £2,294,764 | £2,303,695 | £855,638 | £497,465 | £616,475 | £579,260 |
| Shareholder Funds | £2,494,684 | £2,294,764 | £2,303,695 | £855,638 | £497,465 | £616,475 | £579,260 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 October 2026 | Cessation of a person with significant control | |||
| 25 June 2026 | Total exemption full accounts | 31 December 2025 | ||
| 17 May 2026 | Notification of a person with significant control | |||
| 17 May 2026 | Confirmation statement with updates | 17 February 2026 | ||
| 12 February 2026 | Registration of a charge |
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →